Search research articles
Contact Us
Filters
Showing results (1-10 of 128) with videos related to
Page
of 13
Sort By:
Muscle & Nerve
|
July 23, 2020
Personalized medicine for children with spinal muscular atrophy: Toward the holy grail
Arlene D'Silva, Michelle A Farrar
The Lancet. Child & Adolescent Health
|
July 1, 2026
A decade of disease-modifying therapies for spinal muscular atrophy
Sharika Raga, Michelle A Farrar
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 22, 2014
The Genetics of Spinal Muscular Atrophy: Progress and Challenges
Michelle A Farrar, Matthew C Kiernan
Nature Reviews. Neurology
|
September 26, 2020
Spinal muscular atrophy - the dawning of a new era
Michelle A Farrar, Matthew C Kiernan
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 12, 2020
Treating adults with spinal muscular atrophy with nusinersen
Michelle A Farrar, Matthew C Kiernan
Australian Journal of General Practice
|
January 31, 2022
The changing therapeutic landscape of spinal muscular atrophy
Joanne E Davidson, Michelle A Farrar
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 23, 2012
No gain - no pain?
Cindy Shin-Yi Lin, Michelle A Farrar
The Lancet. Neurology
|
August 16, 2025
The evolving landscape of spinal muscular atrophy treatment
Aicee Dawn Calma, Steve Vucic, Michelle A Farrar
Nature Reviews. Neurology
|
May 7, 2026
Newborn screening for spinal muscular atrophy: time is motor neuron
Didu S Kariyawasam, Giovanni Baranello, Michelle A Farrar
Nutrition Reviews
|
January 23, 2020
Nutritional practices in pediatric patients with neuromuscular disorders
Emile Chou, Rachel Lindeback, Hugo Sampaio, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 128) with videos related to
Sort By:
Page
of 13
Muscle & Nerve
|
July 23, 2020
Personalized medicine for children with spinal muscular atrophy: Toward the holy grail
Arlene D'Silva, Michelle A Farrar
The Lancet. Child & Adolescent Health
|
July 1, 2026
A decade of disease-modifying therapies for spinal muscular atrophy
Sharika Raga, Michelle A Farrar
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 22, 2014
The Genetics of Spinal Muscular Atrophy: Progress and Challenges
Michelle A Farrar, Matthew C Kiernan
Nature Reviews. Neurology
|
September 26, 2020
Spinal muscular atrophy - the dawning of a new era
Michelle A Farrar, Matthew C Kiernan
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 12, 2020
Treating adults with spinal muscular atrophy with nusinersen
Michelle A Farrar, Matthew C Kiernan
Australian Journal of General Practice
|
January 31, 2022
The changing therapeutic landscape of spinal muscular atrophy
Joanne E Davidson, Michelle A Farrar
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 23, 2012
No gain - no pain?
Cindy Shin-Yi Lin, Michelle A Farrar
The Lancet. Neurology
|
August 16, 2025
The evolving landscape of spinal muscular atrophy treatment
Aicee Dawn Calma, Steve Vucic, Michelle A Farrar
Nature Reviews. Neurology
|
May 7, 2026
Newborn screening for spinal muscular atrophy: time is motor neuron
Didu S Kariyawasam, Giovanni Baranello, Michelle A Farrar
Nutrition Reviews
|
January 23, 2020
Nutritional practices in pediatric patients with neuromuscular disorders
Emile Chou, Rachel Lindeback, Hugo Sampaio, et al.
Page
of 13